Skip to Content
Merck
  • Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors.

Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors.

The Journal of pharmacy and pharmacology (2012-07-11)
Ian M Coupar, Helen R Irving, David T Manallack, Yean Y Tan, Fadi Ayad, Juliana Di Iulio, Nathalie Tochon-Danguy, Magdy N Iskander
ABSTRACT

The aim was to examine the biological activity of 5-methoxytryptamine derivatives at the 5-hydroxytryptamine (5-HT)(4) receptor to explore the effect of substitution on the aliphatic amine of the 5-methoxyamine scaffold. Three compounds were tested for affinity at the 5-HT(4) receptor by radioligand binding and functional activity using guinea-pig ileum and human colon circular muscle preparations and also in the mouse whole gut transit test. The three compounds all had agonist properties at the 5-HT(4) receptor but their efficacy differed in the different functional tests. Compound 3 had the highest affinity for the 5-HT(4) receptor and was a full agonist at relaxing human colon circular muscle with efficacy closest to 5-HT. Compounds 1 and 2 were partial agonists in this assay with lower efficacies; compound 2 was a full agonist in the guinea-pig ileum assay whereas compound 3 was a partial agonist. Compounds 1 and 2 also showed activity in the mouse gut transit assay while compound 3 had no activity. Of the compounds tested, compound 3 was the most promising 5-HT(4) receptor agonist and the results highlight the value of using human tissue in functional tests when assessing compounds for potential activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Methoxyamine hydrochloride, 98%
Sigma-Aldrich
5-Methoxytryptamine, 97%
Sigma-Aldrich
5-Methoxyindole, 99%